DISCLOSURE STATEMENTS FOR
National Rx Drug Abuse Summit 2012
In accordance with the policies on disclosure of The Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center’s Commission on Accreditation (ANCC), National Association of Social Workers (NASW), and the National Board for Certified Counselors (NBCC), presenters for this conference have been asked and are expected to identify whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentations(s).
THE FOLLOWING INFORMATION WAS DISCLOSED
Shelley Caplan has disclosed that she is an employee IQ Solutions, Inc.
Roseline Hooks has disclosed that she is an employee IQ Solutions, Inc.
Benjamin Lok, Ph.D. has disclosed that he is a shareholder in Shadow Health, Inc.
Fred Wells Brason II has disclosed that he receives research support from and is a consultant for Purdue Pharma, LP.
Erin Johnson, MPH wishes to disclose the following: contract work with Miller Medical Communication, LLC.
Nathaniel P. Katz, MD, MS is employed by Analgesic Solutions, a clinical research and consulting firm that receives research grants and consulting fees from multiple different industry sponsors including pharmaceutical and medical device companies. Dr. Katz has disclosed that he is a consultant for Abbot, Astellas, AstraZeneca, BDSI, Biogen, BMS, Calosyn, Cephalon, Collegium, Covidien, Depomed, Depuy, Durect, Galderma, Grunenthal, Iroko, JNJ, Merck, Neuraxon, NeurogesX, Nuvo, Orexo, Pfizer, Purdue, Relmada, Respironics, SciClone, and Zogenix. Dr. Katz receives grant/research support from Astellas, BMS, Cephalon, JNJ, Merck, Pfizer, Purdue, and Zogenix. Dr. Katz is also on the Scientific Advisory Board for NeurogesX.
Robert I.L. Morrison has disclosed that he has a relationship with Alkarmes and Reckitt Benckiser.
Kathryn Mueller, MD, MPH has disclosed that she is on the Speaker’s Bureau of the American College of Occupational and Environmental Medicine.
Joseph Paduda has disclosed that he receives research Reckitt Benckiser’s Suboxone Sublingual Film
Stephen J. Pasierb, M.Ed. has disclosed that he is the President & CEO of The Partnership at Drugfree.org. The Partnership has unrestricted funding relationships with several entities in the pharmaceutical industry. These funds support abuse prevention, intervention and treatment referral services.
A. Phillip Walls, R.Ph. has disclosed that he will discuss the off-label use of
drugs such as Actiq and Fentora that create a high risk environment for
developing addiction.
Lynn Webster, MD has disclosed that he is a consultant, receives honoraria or is on the advisory board for AlphaBioCom, the American Academy of Pain Management. American Board of Pain Management, Boston Scientific, Cephalon, Inc., Coviden Mallinckrodt, and Pfizer. He also receives research support from Adolor Corp., Alkermes, Inc., Allergan Inc., Astellas, AstraZeneca, Bayer Healthcare, BioDelivery Systems International, Boston Scientific, Cephalon, Collegium Pharmaceuticals, Covidien, Eisai, Elan Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Identigene (Sorenson), King Pharmaceuticals, Meagan Medical, Medtronic, Merck, Naurex, Nektar Therapeutics, NeurogesX, Inc., Novartis, Pfizer, SchaBar, Shionogi USA Inc, St. Renatus, SuCampo Pharma Americas, USA, Takeda, TEVA Pharmaceuticals (Sub-I), Theravance, Inc., Vanda, Vertex, Xanodyne Pharmaceuticals.
NO SIGNIFICANT FINANCIAL RELATIONSHIP
REPORTED BY PRESENTER
CE/CME Planning Committee: The planners/managers of the CE/CME activity have no financial relationships to disclose relating to the content of this activity.
Daniel P. Alford, MD, MPH, FACP, FASAM
Hon. Dave Aronberg
Sarah Ball, PharmD
Leslie Balonick
Michael C. Barnes, Esq.
Deborah Beck, MSW
Marylou Behnke, MD
Vice Admiral Regina Benjamin, MD, MBA
William A. Benson, CFE
Kristine Harper Bowers
Carol J. Boyd, PhD, RN, FAAN
Det. Ryan Buzzini
Alex Cahana, MD, MAS, DAAPM, FIPP
Kelly J. Clark, MD, MBA, DFAPA
Thomas W. Clark, BA
Jeremy J. Corbett, MD
Judy Cushing
Officer Cully Desmond
Agent Bruce DiVincenzo
Florida SADD/ University High School SADD Chapter
Gary M. Franklin, MD, MPH
Beverly Franklin-Thompson, PharmD
Rollin M. Gallagher, MD, MPH
Michael Gavin, MBA
Hon. Sherry L. Green, JD
Frances M. Harding
Rebecca Heuser
David R. Hopkins
Dennis Jay
Andrew Kolodny, MD
Barbara Krantz, DO, MS
Peter Kreiner, PhD
CDR Jinhee Lee, PharmD
Michelle Lipinski, MEd
Jon Marshall
Gary Martin, EdD
Karen Matthew, MA
Mike Mayer
Elinore F. McCance-Katz, MD, PhD
Hon. Alix C. Michel, JD
Hon. John Niedermann, JD
Karen H. Perry
Peggy Quigg
Richard R. Rosky
Kay Roussos Ross, MEd, MPAS
Peggy B. Sapp, BS
Dan Smoot
Brian K. Solow, MD, FAAFP
Dr. Henry Spiller
Robert Sproul, PharmD
Hon. Vernon Stejskal
Hon. Kate Tipping
Mike Townsend
Peter Van Pelt, RPh
Richard A. Victor, JD, PhD
Nora D. Volkow, MD
Hon. David J. Ward, JD
Tamara D. Warner, PhD
Gregory C. Warren, MA, MBA
Hon. Roger W. West, JD
Leonard Young, MS, MA
DISCLAIMER STATEMENT
The information presented at this ACCME/ACPE/ANCC/NASW/NBCC conference represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, Inquisit, Creative Educational Concepts, Inc. or Operation UNITE. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with accreditation/regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnosis or treatment decisions including, without limitations, FDA-approved uses and any off label uses.